Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-084836
Filing Date
2025-06-11
Accepted
2025-06-11 16:15:08
Documents
2
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1565
2 EX-24 rlay-ex24.htm EX-24 10237
  Complete submission text file 0000950170-25-084836.txt   13238
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Issuer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703 BOSTON MA 02116
Business Address
Mazumdar Claire (Reporting) CIK: 0002034671 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39385 | Film No.: 251040171